KRTAP5-9: A Potential Drug Target and Biomarker (G3846)

Target Name: KRTAP5-9

NCBI ID: G3846

KRTAP5-9

KRTAP5-9: A Potential Drug Target and Biomarker

Keratin-associated protein 5-9 (KRTAP5-9) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function make it an intriguing candidate for research and development as a new drug or diagnostic agent.

The protein KRTAP5-9 is a member of the Keratin family, which is known for their role in the development and maintenance of hair and nails. It is composed of 21 kilodalton (kDa) of amino acids and is expressed in various tissues, including skin, hair, nails, and the nervous system. KRTAP5-9 is highly conserved across different species, which indicates that it has a critical role in the development and maintenance of tissues.

KRTAP5-9 has been shown to play a significant role in various physiological processes, including cell signaling, tissue repair, and inflammation. It is involved in the regulation of cell growth, differentiation, and apoptosis, as well as in the production of extracellular matrix (ECM) components, such as collagen and elastin.

One of the most significant functions of KRTAP5-9 is its role in the regulation of cell signaling. It is a well-known protein that can interact with various signaling molecules, including TGF-β1, a key regulator of cell signaling. KRTAP5-9 has been shown to play a negative role in the regulation of TGF-β1 signaling, which is associated with the development of various diseases, including cancer.

In addition to its role in cell signaling, KRTAP5-9 is also involved in the regulation of tissue repair and inflammation. It has been shown to play a significant role in the regulation of cell division and the production of new cells, which is critical for tissue repair and regeneration after injury or disease. It is also involved in the regulation of inflammation, which is critical for immune response and the fight against infection.

KRTAP5-9 has also been shown to be involved in the development and maintenance of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these diseases makes it an attractive candidate for drug targeting and research. For example, KRTAP5-9 has been shown to be involved in the development of various types of cancer, including breast, ovarian, and prostate cancer. It is also involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, as well as in the development of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

Given its unique structure and function, KRTAP5-9 has potential as a drug target or biomarker for a variety of diseases. Its role in cell signaling, tissue repair, and inflammation make it an attractive candidate for targeting with small molecules or other therapeutic agents. Additionally, its conservation across different species makes it a valuable resource for the development of new diagnostic tests.

In conclusion, KRTAP5-9 is a protein that has significant potential as a drug target or biomarker for various diseases. Its unique structure and function make it an intriguing candidate for research and development in the field of drug discovery. Further studies are needed to fully understand its role in various physiological processes and its potential as a therapeutic agent.

Protein Name: Keratin Associated Protein 5-9

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP5-9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP5-9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets